CClinicalTrials.gg
Active, not recruitingNCT02872402DEPARTUpdated Apr 8, 2022

Feasibility of a Postpartum Lifestyle Intervention on the Cardiometabolic Risk Profile of GDM Women

An interventional study of Lifestyle intervention and Active control lifestyle intervention in Dietary Modification, Weight Loss and Physical Activity, sponsored by Laval University. Active, not recruiting at 1 site in Canada. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-08.

Sponsored by Laval University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of the study is to investigate the effect of a lifestyle intervention program (adoption of exclusive breastfeeding, healthy diet and regular physical activity) on minimizing postpartum weight retention among women with recent GDM.

Read the detailed description

Women with a history of gestational diabetes (GDM) are characterized by increased risk for subsequent type 2 diabetes (T2D) and cardiovascular disease (CVD). These women are also characterized by higher body mass index (BMI) and waist circumference compared to women without prior GDM. Failure to lose the weight gained during pregnancy can lead to increased BMI for subsequent pregnancies. As such, the childbearing-age period has been described as a potential period of weight gain and represents a critical window for the development of obesity, T2D and CVD. Therefore, strategies aiming at preventing postpartum weight retention (WR) and early cardiometabolic alterations in women with a history of GDM are of paramount importance. Principal investigator have shown that a low diet quality score was associated with greater adiposity and lower insulin sensitivity in women with prior GDM. Furthermore, less than 10% of women with prior GDM met the recommendations for breastfeeding, nutrition, and physical activity. Investigators have shown that attitude and perceived behavioral control were significant predictors of the intention to adopt healthy eating. For those who did engage in healthy behaviors, lower prevalence of cardiometabolic alterations was observed, providing supportive evidence that the adoption of healthy behaviors may be key to prevent the progression to an altered cardiometabolic profile.

02

Conditions studied

  • Dietary Modification
  • Weight Loss
  • Physical Activity
  • Breastfeeding

Browse trials for

Keywords

  • gestational diabetes
  • dietary modification
  • weight loss
  • physical activity
  • breastfeeding
03

In context

Weight Loss

1,766 studies on the registry are indexed under Weight Loss; 277 are open to participants now.

This study's planned enrollment of 30 is below the median of 73 across 1,496 interventional studies indexed under Weight Loss.

Browse Weight Loss studies →

Lead sponsor

Laval University is the lead sponsor of 371 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Pregnant women diagnosed with GDM
  • Fluent in French
  • Had a singleton pregnancy
  • At least 18 yrs old
  • With a reported pre-pregnancy BMI ≥18.5 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Women who had bariatric surgery
  • Women who plan another pregnancy in the following year
  • Women with a history of type 1 or type 2 diabetes
  • Women with a multiple pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Intervention group

    At 2-mo postpartum, women will start the 1-yr lifestyle intervention that will consist of 7 face-to-face individual sessions of 1-hr (at 2, 3, 4, 5, 6, 9, 12 mo postpartum and a follow-up at 18 mo). Metabolic and anthropometric measurements will be assessed at 2,6,12 and 18 mo postpartum. In addition, 7 individual sessions of 30 min between face-to-face sessions will be carried out on the phone. Benefits of exclusive breastfeeding, healthy eating and physical activity will be portrayed at each visit .

    Behavioral: Lifestyle intervention

  • Active comparator
    Active control lifestyle intervention

    Women in the control group will come to the testing unit at 2, 6, 12 and 18 mo postpartum for metabolic and anthropometric measurements and at 3, 4, 5, 9 mo for weight measurements only. They will receive standard lifestyle recommendations in the form of written information at each visit.

    Behavioral: Active control lifestyle intervention

Interventions

  • BehavioralLifestyle intervention

    Women who are still breastfeeding at the first postpartum visit will be encouraged to pursue. References to local breastfeeding supporting groups will be done, if needed. The intervention will be conducted in order to reach recommendations for food servings and nutrient needs. Particular attention will be paid to increase fruits, vegetables, fish and whole grains intake, and decrease added sugars and high fat meat/dairy products. Women will be strongly encouraged to be active at least 150 min/week. They will be provided with targeted strategies for exercising, types of exercises and tips for including physical activity into the daily routine as well as fun exercises for the whole family.

  • BehavioralActive control lifestyle intervention

    Participants in the control group will receive standard lifestyle recommendations in the form of written information at each visit.

06

What researchers measure

Primary outcomes

  1. Weight retention

    Time frame: 12 months postpartum

Secondary outcomes

  1. Waist circumference

    Time frame: 12 months postpartum

  2. Body composition

    Time frame: 12 months postpartum

  3. Glucose

    Time frame: 12 months

  4. Insuline

    Time frame: 12 months

  5. Oral glucose tolerance test (75g)

    Time frame: 12 months

  6. Glycated hemoglobin

    Time frame: 12 months

  7. Lipid profile

    Time frame: 12 months

  8. Resting blood pressure

    Time frame: 12 months

  9. Breastfeeding duration

    , time physically active

    Time frame: 12 months

  10. Healthy eating index

    Time frame: 12 months

  11. Time physically active

    Time frame: 12 months

07

Study locations

1 site
  • Institut sur la nutrition et les aliments fonctionnels
    Quebec City, Quebec G1V0A6, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02872402
Lead sponsor
Laval University
Responsible party
Julie Robitaille (Associate Professor, Laval University) — Principal investigator
First posted
Aug 19, 2016
Start date
Dec 2016
Primary completion
Oct 2020
Completion
Dec 2025 (estimated)
Last update
Apr 8, 2022

Study contacts

Julie Robitaille, RD PhD
principal investigator · Laval University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion